No headlines found.
Market Signals Highlight Next Wave of Immunotherapy Growth (OSTX, IBRX)
AB Digital Inc (Tue, 16-Dec 3:16 PM ET)
Newsfile (Mon, 15-Dec 6:00 AM ET)
Newsfile (Tue, 9-Dec 7:40 AM ET)
OS Therapies Announces FDA PDUFA Waiver & EMA Grants Union Marketing Authorisation Eligibility
Newsfile (Fri, 5-Dec 8:02 AM ET)
Newsfile (Tue, 25-Nov 9:21 AM ET)
OS Therapies to Spinoff OS Animal Health into Standalone Public Company
Newsfile (Thu, 20-Nov 7:40 AM ET)
OS Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
Newsfile (Mon, 17-Nov 6:00 AM ET)
Newsfile (Wed, 22-Oct 9:15 AM ET)
Newsfile (Fri, 17-Oct 9:15 AM ET)
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.
Os Therapies trades on the AMEX stock market under the symbol OSTX.
As of December 26, 2025, OSTX stock price declined to $1.51 with 284,638 million shares trading.
OSTX has a beta of -0.01, meaning it tends to be less sensitive to market movements. OSTX has a correlation of 0.00 to the broad based SPY ETF.
OSTX has a market cap of $53.17 million. This is considered a Micro Cap stock.
Last quarter Os Therapies reported $0 in Revenue and -$.21 earnings per share. This fell short of revenue expectation by $-28 million and missed earnings estimates by -$.08.
The top ETF exchange traded funds that OSTX belongs to (by Net Assets): VXF, VTI, IWC.
OSTX has underperformed the market in the last year with a price return of -70.4% while the SPY ETF gained +16.0%. OSTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -26.3% and -16.6%, respectively, while the SPY returned +4.6% and +1.5%, respectively.
OSTX support price is $1.45 and resistance is $1.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSTX shares will trade within this expected range on the day.
